Current stage -Stage III - Page 2 of 3 Posts on Medivizor
Navigation Menu

Current stage -Stage III Posts on Medivizor

Identifying prostate cancer progression

Posted by on Apr 29, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to identify the best options available to identify metastatic prostate cancer. Some background Metastatic prostate cancer is cancer that has spread from the prostate gland into tissues and organs around the body. In some cases patients with metastatic cancer can become resistant to certain treatments, such as...

Read More

The complications associated with hormone therapy in advanced prostate cancer

Posted by on Apr 29, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the complications of hormone therapy in patients with advanced prostate cancer.  Some background Hormone therapy is a prostate cancer treatment that targets the male sex hormones, such as testosterone, active in cancer. In some patients hormone therapy can cause side effects such as bone damage,...

Read More

Is early adjuvant radiotherapy associated with different outcomes compared to delayed therapy?

Posted by on Aug 3, 2014 in Prostate cancer | 0 comments

In a nutshell The authors evaluated the optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer. Some background Radical  prostatectomy (surgery to remove the prostate) remains the most common treatment for localized prostate cancer (has not spread beyond the prostate)...

Read More

IGF-R; a new target for prostate cancer treatment?

Posted by on Feb 13, 2014 in Prostate cancer | 0 comments

In a nutshell This review explored the use of insulin-like growth factor receptor blockers as treatment for castration-resistant prostate cancer. Some background Prostate cancer is dependent on androgens, male hormones such as testosterone, for growth. Therefore androgen deprivation therapy, which blocks the production or action of testosterone...

Read More

Reducing the risk of bone fractures

Posted by on Nov 28, 2013 in Prostate cancer | 0 comments

In a nutshell This review examined the safety and efficacy of zoledronic acid (Zometa) and denosumab (Xgeva), two treatments for bone loss related to advanced prostate cancer. Some background Advanced prostate cancer (PC) can be associated with bone damage caused by bone metastases (cancer that has spread to the bones) or by androgen deprivation...

Read More

Surgery or targeted radiotherapy?

Posted by on Nov 24, 2013 in Prostate cancer | 0 comments

In a nutshell This examined survival rates of radical prostatectomy compared with intensity modulated radiotherapy (IMRT) among patients with localized (confined) prostate cancer.  Some background Radical prostatectomy or RP (surgical removal of the prostate gland and some healthy tissue around it) and radiotherapy are the most common...

Read More

Comparing therapies in the treatment of high-risk prostate cancer patients

Posted by on Jul 11, 2013 in Prostate cancer | 0 comments

In a nutshell This study compared the effects of different therapies in the treatment of high-risk prostate cancer. Failure of treatment and mortality rates were compared between the use of external beam radiotherapy (EBRT) and combined modality radiotherapy (CMRT). The effect of adding androgen deprivation therapy (ADT) to the treatment plan...

Read More

Comparing three different methods of radiation therapy and their effects on quality of life in patients with prostate cancer

Posted by on Jun 30, 2013 in Prostate cancer | 0 comments

In a nutshell This article looked at the effects of radiation therapy on bowel and urinary function in patients with prostate cancer. Three different methods of radiation therapy were compared:intensity-modulated radiotherapy (IMRT), proton beam therapy (PBT) and 3-dimensional conformal radiation therapy (3DCRT). Some background Radiation therapy...

Read More

Comparing survival for surgery versus radiation therapy in patients with prostate cancer

Posted by on Jun 26, 2013 in Prostate cancer | 0 comments

In a nutshell This study compared survival rates for patients with prostate cancer who were treated with either surgery to remove the prostate (radical prostatectomy) or radiation therapy (external beam radiotherapy).  Some background The prostate is a gland in the reproductive system of men, which is found under the urinary bladder. In a...

Read More

The impact of 6 vs 18 months of androgen-suppression therapy, with or without Zolendronic Acid, on quality of life in men with prostate cancer

Posted by on Mar 3, 2013 in Prostate cancer | 0 comments

In a nutshell This clinical trial evaluated the quality of life of men with locally advanced prostate cancer (PCa) treated with Leuprorelin and radiotherapy, with or without Zolendronic Acid (ZA). Quality of life measures improved with shorter duration of Leuprorelin treatment, regardless of combining ZA. Some background Prostate cancer...

Read More